Capital Advisors, Ltd. LLC Bristol Myers Squibb CO Transaction History
Capital Advisors, Ltd. LLC
- $885 Million
- Q3 2025
A detailed history of Capital Advisors, Ltd. LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 2,539 shares of BMY stock, worth $118,850. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,539
Previous 2,935
13.49%
Holding current value
$118,850
Previous $136,000
15.44%
% of portfolio
0.01%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,681Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...